COBAN 2 LITE LAYER COMPRESSION SYSTEM 2794

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,s report with the FDA on 2017-12-11 for COBAN 2 LITE LAYER COMPRESSION SYSTEM 2794 manufactured by 3m Health Care.

Event Text Entries

[94482910] A 4-6 information was not supplied by reporter. Pulmonary embolism occurs at a known rate postoperatively following joint replacement surgery. When the report was received on (b)(6) 2017, there was no evidence to suggest that the occurrence of the pulmonary embolism was related to the use of 3m coban 2 lite layer compression system post total knee arthroplasty. On (b)(6) 2017 3m received the 4th report of a pulmonary embolism in this study. Threem contacted the study investigators to obtain additional patient details regarding operative duration, patient comorbidities and medical history. No additional information has been received to date. Although there was still no evidence to suggest that the occurrence of pulmonary embolism was related to the use of 3m coban 2 lite layer compression system post total knee arthroplasty, on (b)(6) 2017 3m made the decision to send mdr reports for all four cases. Case 2110898-2017-000146 was sent for report received on (b)(6) 2017. On (b)(6) 2017 mdr report numbers 2110898-2017-00148, 2110898-2017-00149 and 2110898-2017-00150 were sent based on trend analysis. (b)(4). Threem will continue to monitor complaints and trends for this type of report.
Patient Sequence No: 1, Text Type: N, H10


[94482931] An independent study investigator reported coban 2 lite layer compression system was applied to a (b)(6) male patient following a total knee arthroplasty. On post-op day 2, the patient complained of knee pain and the wrap was removed for further investigation and tests. Later the same day, a diagnosis of pulmonary embolism was confirmed. The patient reportedly received full anticoagulation treatment.
Patient Sequence No: 1, Text Type: D, B5


[106422724] 3m received a formal letter from the university (b)(6) regarding their investigation of the four pulmonary embolisms that occurred within the investigator-initiated research study entitled "the use of 3m? Coban? 2 lite layer compression system post-total knee arthroplasty". The university (b)(6) consulted with two independent content experts to investigate the etiology of the pulmonary embolisms and to determine whether they were related to the study intervention, i. E. , the 3m? Coban? 2 lite layer compression system. In brief, the independent content experts reached consensus that the four pes were likely unrelated to the study intervention 3m? Coban? 2 lite layer compression system.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2110898-2017-00150
MDR Report Key7107295
Report SourceFOREIGN,HEALTH PROFESSIONAL,S
Date Received2017-12-11
Date of Report2018-03-27
Date of Event2017-10-20
Date Mfgr Received2017-12-05
Date Added to Maude2017-12-11
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS KAREN KRENIK, BSN
Manufacturer Street3M CENTER BUILDING 275-5W-06 2510 CONWAY AVE
Manufacturer CityST. PAUL MN 55144
Manufacturer CountryUS
Manufacturer Postal55144
Manufacturer Phone6517333091
Manufacturer G1MANUFACTURING MEDICAL DEVICES
Manufacturer StreetEDISONSTRASSE 6 D-59157
Manufacturer CityKAMEN,
Manufacturer CountryGM
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOBAN 2 LITE LAYER COMPRESSION SYSTEM
Generic NameCOBAN 2 LITE LAYER COMPRESSION SYSTEM
Product CodeFQM
Date Received2017-12-11
Catalog Number2794
Lot NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
Manufacturer3M HEALTH CARE
Manufacturer Address2510 CONWAY AVE ST. PAUL MN 55144 US 55144


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Other 2017-12-11

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.